Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
22 March 2018
General meetings
Third party’s report on the 2017 Company’s CSR report
Open in new window
28 July 2017
Financial statements and reports
2017 Half-Year Financial Report
Open in new window
06 July 2017
Regulated information
Half-Year Report on the Liquidity Contract
Open in new window
23 June 2017
Regulated information
Note d’opĂ©ration visa 17-297
Open in new window
23 June 2017
Regulated information
Securities Note visa 17-397
Open in new window
10 May 2017
General meetings
2016 Registration Document
Open in new window
10 May 2017
General meetings
Supplementary report of the Board on the issuance of ordinary shares on July 12, 2016
Open in new window
10 May 2017
General meetings
Table of summary results for the past 5 years
Open in new window
10 May 2017
General meetings
Supplementary report of the Board on the issuance of share warrants on July 26, 2016
Open in new window
10 May 2017
General meetings
Auditors’ report on the issuance of share warrants
Open in new window
View previous 9 articles
1
…
14
15
16
17
18
19
20
21
View next 9 articles
Go back to the page of the page